Yayın: Novel Benzylidene Thiazolidinedione Derivatives as Partial PPARγ Agonists and their Antidiabetic Effects on Type 2 Diabetes
| dc.contributor.author | BAYSAL, MERVE | |
| dc.contributor.author | Atlı, Özlem | |
| dc.contributor.author | Antonio Laghezza | |
| dc.contributor.author | Fabrizio Dal Piaz | |
| dc.contributor.author | Fulvio Loiodice | |
| dc.contributor.author | V. Viswanathan | |
| dc.contributor.author | D. Velmurugan | |
| dc.contributor.author | Susanta Mondal | |
| dc.contributor.author | Özlem Atlı | |
| dc.contributor.author | Merve Baysal | |
| dc.contributor.author | Ashok Pattnaik | |
| dc.contributor.author | Venkatesan Jayaprakash | |
| dc.contributor.author | Antonio Lavecchia | |
| dc.contributor.orcid | 0000-0001-8399-1230 | |
| dc.contributor.orcid | 0000-0003-4909-1145 | |
| dc.contributor.orcid | 0000-0001-6221-6155 | |
| dc.contributor.orcid | 0000-0002-8643-5018 | |
| dc.contributor.orcid | 0000-0003-3384-574X | |
| dc.contributor.orcid | 0000-0001-7178-5966 | |
| dc.contributor.orcid | 0000-0001-6465-9769 | |
| dc.contributor.orcid | 0009-0005-9505-0565 | |
| dc.contributor.orcid | 0000-0002-8099-0942 | |
| dc.contributor.orcid | 0000-0003-2931-9042 | |
| dc.contributor.orcid | 0000-0002-9724-4153 | |
| dc.contributor.orcid | 0000-0002-2181-8026 | |
| dc.date.accessioned | 2025-11-13T09:29:55Z | |
| dc.date.issued | 2017-10-25 | |
| dc.identifier.doi | https://doi.org/10.1038/s41598-017-14776-0 | |
| dc.identifier.endpage | 14453 | |
| dc.identifier.issn | 2045-2322 | |
| dc.identifier.issue | 1 | |
| dc.identifier.openalex | W2765770941 | |
| dc.identifier.startpage | 14453 | |
| dc.identifier.uri | https://hdl.handle.net/11421/1325 | |
| dc.identifier.uri | https://doi.org/10.1038/s41598-017-14776-0 | |
| dc.identifier.volume | 7 | |
| dc.language.iso | en | |
| dc.relation.ispartof | Scientific Reports | |
| dc.rights | openAccess | |
| dc.subject | Thiazolidinedione | |
| dc.subject | Rosiglitazone | |
| dc.subject | Chemistry | |
| dc.subject | Glucose homeostasis | |
| dc.subject | Nuclear receptor | |
| dc.subject | Peroxisome proliferator-activated receptor | |
| dc.subject | Receptor | |
| dc.subject | Diabetes mellitus | |
| dc.subject | Pharmacology | |
| dc.subject | Surface plasmon resonance | |
| dc.subject | Internal medicine | |
| dc.subject | Endocrinology | |
| dc.subject | Type 2 diabetes | |
| dc.subject | Biochemistry | |
| dc.subject | Medicine | |
| dc.subject | Insulin resistance | |
| dc.subject | Transcription factor | |
| dc.subject | Materials science | |
| dc.subject | Nanotechnology | |
| dc.subject.sdg | 3 | |
| dc.title | Novel Benzylidene Thiazolidinedione Derivatives as Partial PPARγ Agonists and their Antidiabetic Effects on Type 2 Diabetes | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| local.authorid.openalex | A5027386527 | |
| local.authorid.openalex | A5110553744 |
